Upcoming Allied Market Research
Hematology Diagnostics Market

Hematology Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2022-2029 Market

Report Code: A10991
Pages: NA
Nov 2022 | 834 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hematology Diagnostics Market

Request Now !

Hematology is an offset of medical science that studies blood, blood-forming organs and various diseases related with blood. Hematology majorly deals with issues associated with red blood cells (RBCs), white blood cells (WBCs), lymph, bone marrow and blood platelets. Hematology diagnosis includes a myriad of tests including flow cytometry, blood analysis, hemostasis, cytology, molecular diagnostics, histology, and immunodiagnostics. Hematology diagnosis process is concerned with detection, monitoring of diseases, prognosis and subsequent screening and is extensively used against various blood related diseases such as hemophila, blood cancer and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.

Hematology diagnostic systems include hemostatis, immunohematology, hematology reagents and hematology rapid tests, among which hemostatis being the leading segment in the global hematology diagnostics market.

Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Products, Test types, End Users and Region

  Geographies covered

•             North America (U.S., Canada, Mexico)

•             Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•             Asia-Pacific (Japan, China, India, Australia, South Korea, Rest          of Asia-Pacific)

•             LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Boule Diagnostics AB, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare and Sysmex Corporation.


COVID – 19 scenario analysis: 

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to hematology diagnostics has been reduced and this segment have to face negligence subsequently causing negative impact on hematology diagnostics market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Myriad of factors such as rising prevalence of blood-related diseases along with growing awareness about these diseases and availability of efficient diagnostics is driving the hematology diagnostics market. Additionally, technological advancements in will further propel the market growth in various aspects. The development of highly advanced hematology analyzers, rising utilization of flow cytometry tests in the market and surge in demand for the evolutionary extremely sensitive point-of-care hematology analyzers will help in adoption of these diagnostics in the medical diagnosis industry. The Point-Of-Care (POC) hematology diagnostics are being extensively used due to their user friendliness. They also minimize the requirement for trained personal and also offer remote testing. These features are comparatively better than the conventional systems. Furthermore, these advanced tests also reduce test processing time and give accurate results rapidly. These developments would increase the acceptance of these diagnostic systems globally owing to enhanced attributes than their predecessors.

Developing geographies such as India, Brazil, Mexico and China will serve as growth avenues for the hematology tests market, thereby creating immense opportunities for market expansion. Growing geriatric population resulting into patient pools, rising disposable incomes, supportive government initiatives to spread awareness regarding blood-related disorders and hematology tests and rising of medical tourism owing to higher healthcare expenditure and cost reduction due to standardization of processes are the factors fuelling the growth for hematology diagnostics in developing economies.

Having said that, the hematology market has some restrains such as high cost of diagnosis, and lack of proper healthcare insurance coverage for hematology diagnostic procedures. Moreover, lack of proper healthcare infrastructure and product recalls due are the factors that may impede the market growth for hematology diagnostics.

Increasing incidences of blood related diseases to boost the market

Rise in the frequency of blood related disorders such as anemia, hemophilia, blood cancer, blood clots and others would surge the demand for diagnostics for hematology and have a significant contribution for the market growth. The published article by Bristol-Myers Squibb stated the increasing incidences of blood cancer as almost 1 million cases of the disease are expected to be diagnosed by the year 2020, which accounts for around 6% of the total cancer cases around the world. Additionally, an immense rise in the world populace facing various hemoglobinopathies, would ensure the growth of hematology testing market.

Increased Automation in the hematology diagnostics to surge the demand

Automation in field of hematology diagnostics have allowed the hematology diagnostics laboratories has been one of the emphasis of research and development activities. This has resulted into acceptance of automation in several diagnostic laboratories for pre-analytical, analytical, and post-analytical steps for improvising efficacy of the results and standardize the process. Furthermore, automation has facilitated the diagnostic sample collection, diagnosis process, recognition tests, and other processes and has resulted in reduction of administrative errors and provide with accurate results. These factors would surge the demand for hematology diagnostics thereby, augmenting the market growth.

Key segments:




  • Instrument
  • Consumables
  • Reagents
  • Stains
  • Others

Test type

  • Blood count
  • Platelet function
  • Hemoglobin
  • Hematocrit

  End users

  • Hospitals
  • Diagnostic laboratories
  • Others


  • North America
  • Europe
  • Asia-Pacific


Key benefits of the report:

  • This study presents the analytical depiction of the global hematology diagnostics industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global hematology diagnostics market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight hematology diagnostics market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global hematology diagnostics market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Hematology diagnostics market research report:

  • What are the leading market players active in the hematology diagnostics market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Hematology Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Product
  • Instrument
  • Consumables
  • Reagents
  • Stains
  • Others
By Test Type
  • Blood count
  • Platelet function
  • Hemoglobin
  • Hematocrit
By End User
  • Hospitals
  • Diagnostic laboratories
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Abbott Laboratories, Beckman Coulter Inc, Bio-Rad Laboratories Inc, Boule Diagnostics AB, Horiba Ltd, Mindray Medical International Limited, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, Sysmex Corporation.
Other Players Agilent Technologies

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Hematology Diagnostics Market

Start reading.
This Report and over 19,297+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers